

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.35976513 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.09515164 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.09515164 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69649863 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.50209235 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.24731559 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.19508434 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.19508434 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.19508434 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.19508434 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.19508434 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.19508434 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.09609841 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08764314 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.03218246 |
| 16 | cellular extravasation (GO:0045123) | 4.02502965 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.84746041 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77927653 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73741806 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.73117462 |
| 21 | detection of other organism (GO:0098543) | 3.71773957 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70739756 |
| 23 | negative T cell selection (GO:0043383) | 3.66663101 |
| 24 | activated T cell proliferation (GO:0050798) | 3.65193065 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62919042 |
| 26 | detection of bacterium (GO:0016045) | 3.60180913 |
| 27 | response to peptidoglycan (GO:0032494) | 3.52369307 |
| 28 | tolerance induction (GO:0002507) | 3.46618559 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.46114686 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.45458965 |
| 31 | leukocyte aggregation (GO:0070486) | 3.44931720 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43477810 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.42902415 |
| 34 | response to muramyl dipeptide (GO:0032495) | 3.41564138 |
| 35 | neutrophil activation (GO:0042119) | 3.37973660 |
| 36 | response to interleukin-15 (GO:0070672) | 3.34214653 |
| 37 | microglial cell activation (GO:0001774) | 3.21845864 |
| 38 | T cell selection (GO:0045058) | 3.20438508 |
| 39 | positive T cell selection (GO:0043368) | 3.18350292 |
| 40 | cellular response to interleukin-15 (GO:0071350) | 3.17118226 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.15611501 |
| 42 | regulation of mast cell activation (GO:0033003) | 3.13809562 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12041971 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.11185802 |
| 45 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10057117 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.07897359 |
| 47 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04399199 |
| 48 | granulocyte activation (GO:0036230) | 3.02408332 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.02345897 |
| 50 | thymic T cell selection (GO:0045061) | 3.00934566 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 3.00370660 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.00048131 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.98666156 |
| 54 | germinal center formation (GO:0002467) | 2.97710853 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94695586 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 2.93868543 |
| 57 | negative regulation of interleukin-6 production (GO:0032715) | 2.93714311 |
| 58 | macrophage activation (GO:0042116) | 2.91324635 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90912674 |
| 60 | response to host immune response (GO:0052572) | 2.89716306 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89716306 |
| 62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87004136 |
| 63 | positive regulation of granulocyte differentiation (GO:0030854) | 2.85810470 |
| 64 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83378350 |
| 65 | negative regulation of interleukin-1 production (GO:0032692) | 2.82156233 |
| 66 | defense response to protozoan (GO:0042832) | 2.81424221 |
| 67 | detection of biotic stimulus (GO:0009595) | 2.81154793 |
| 68 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.80070784 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79355908 |
| 70 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.77996468 |
| 71 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77738721 |
| 72 | interferon-gamma production (GO:0032609) | 2.73354170 |
| 73 | neutrophil mediated immunity (GO:0002446) | 2.72631013 |
| 74 | cellular response to exogenous dsRNA (GO:0071360) | 2.71762165 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.71673631 |
| 76 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.71533764 |
| 77 | leukocyte degranulation (GO:0043299) | 2.69940912 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 2.69024953 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69024953 |
| 80 | mannose metabolic process (GO:0006013) | 2.69018734 |
| 81 | response to host (GO:0075136) | 2.68237496 |
| 82 | response to host defenses (GO:0052200) | 2.68237496 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68237496 |
| 84 | dendritic cell migration (GO:0036336) | 2.67220175 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67049350 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.66269940 |
| 87 | histone H3-K4 trimethylation (GO:0080182) | 2.66093904 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 2.66067343 |
| 89 | T cell migration (GO:0072678) | 2.66043180 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.66040279 |
| 91 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.65940552 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.65865967 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65663277 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65258305 |
| 95 | response to protozoan (GO:0001562) | 2.63188299 |
| 96 | mast cell activation (GO:0045576) | 2.60641896 |
| 97 | regulation of T cell tolerance induction (GO:0002664) | 2.58812798 |
| 98 | cellular response to ethanol (GO:0071361) | 2.57834816 |
| 99 | negative regulation of adaptive immune response (GO:0002820) | 2.57274804 |
| 100 | response to type I interferon (GO:0034340) | 2.57157318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.97322388 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26986396 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03266969 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84681409 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.79160458 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62503194 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.57968042 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51471974 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42567539 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37209031 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21765228 |
| 12 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16029890 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11247111 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02049634 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 1.97483754 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90316280 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88576743 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 1.88114119 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.87802574 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87772924 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83012549 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77248008 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70255570 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.66750427 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.65126981 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61467078 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 1.57555404 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55527526 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52956156 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51102914 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50740626 |
| 32 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49278014 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49112215 |
| 34 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48066826 |
| 35 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47525270 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.47371826 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44542113 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43535003 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42521214 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.42367152 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37770304 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33863912 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32719232 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32050967 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31050961 |
| 46 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27794686 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.27521757 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27320900 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26757088 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26684431 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26198090 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22917573 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22168362 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21768792 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20078820 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17925945 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16597581 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14765521 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14596962 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09226107 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07581046 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05709346 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04930723 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02535458 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01572589 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00564739 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98296482 |
| 68 | P300_27268052_Chip-Seq_Bcells_Human | 0.97215092 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95968670 |
| 70 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95662867 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95031354 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94413490 |
| 73 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94321444 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94260034 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 0.93801736 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92462904 |
| 77 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92434067 |
| 78 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92216872 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91685374 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91162170 |
| 81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90698057 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90019121 |
| 83 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89583312 |
| 84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88761882 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87355113 |
| 86 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86826758 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85927098 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84807800 |
| 89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81991986 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81875074 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81757681 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81411362 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81153683 |
| 94 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80376367 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.79851836 |
| 96 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.79837202 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.79706876 |
| 98 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79321974 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79128734 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78768106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.01155232 |
| 2 | MP0003436_decreased_susceptibility_to | 4.00041639 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.33229288 |
| 4 | MP0001800_abnormal_humoral_immune | 3.03408035 |
| 5 | MP0005671_abnormal_response_to | 2.97656282 |
| 6 | MP0000685_abnormal_immune_system | 2.87152440 |
| 7 | MP0001790_abnormal_immune_system | 2.79195522 |
| 8 | MP0005387_immune_system_phenotype | 2.79195522 |
| 9 | MP0002419_abnormal_innate_immunity | 2.71231749 |
| 10 | MP0003303_peritoneal_inflammation | 2.64445521 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.59187548 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.57200477 |
| 13 | MP0002723_abnormal_immune_serum | 2.54257770 |
| 14 | MP0005025_abnormal_response_to | 2.53848248 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.43016296 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.42319628 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.39752978 |
| 18 | MP0001819_abnormal_immune_cell | 2.37826485 |
| 19 | MP0009785_altered_susceptibility_to | 2.27372123 |
| 20 | MP0006082_CNS_inflammation | 2.18216085 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.13565284 |
| 22 | MP0002405_respiratory_system_inflammati | 2.01378178 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.00853397 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.00320541 |
| 25 | MP0004381_abnormal_hair_follicle | 1.94420024 |
| 26 | MP0003866_abnormal_defecation | 1.85452518 |
| 27 | MP0000716_abnormal_immune_system | 1.82166591 |
| 28 | MP0001873_stomach_inflammation | 1.81985640 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.79294840 |
| 30 | MP0004947_skin_inflammation | 1.73580433 |
| 31 | MP0002398_abnormal_bone_marrow | 1.72315459 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.69119840 |
| 33 | MP0009278_abnormal_bone_marrow | 1.64261155 |
| 34 | MP0009764_decreased_sensitivity_to | 1.61881417 |
| 35 | MP0005310_abnormal_salivary_gland | 1.55955007 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.54363135 |
| 37 | MP0002933_joint_inflammation | 1.52628688 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.47116823 |
| 39 | MP0003828_pulmonary_edema | 1.46479563 |
| 40 | MP0003045_fibrosis | 1.44979452 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.40942661 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.40307393 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.37508369 |
| 44 | MP0002722_abnormal_immune_system | 1.36194097 |
| 45 | MP0002429_abnormal_blood_cell | 1.34303289 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.29229271 |
| 47 | MP0003646_muscle_fatigue | 1.28577952 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.27902339 |
| 49 | MP0004130_abnormal_muscle_cell | 1.27228001 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.25703135 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.24300415 |
| 52 | MP0008469_abnormal_protein_level | 1.21230850 |
| 53 | MP0004883_abnormal_blood_vessel | 1.19319998 |
| 54 | MP0001663_abnormal_digestive_system | 1.18846086 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.16114400 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.15100063 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.12468656 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.11560211 |
| 59 | MP0002653_abnormal_ependyma_morphology | 1.09490586 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.08992085 |
| 61 | MP0003878_abnormal_ear_physiology | 1.08992085 |
| 62 | MP0001851_eye_inflammation | 1.07732957 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.05830226 |
| 64 | MP0002009_preneoplasia | 1.05791694 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.05496482 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.05496482 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.05045974 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.01528612 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.01152530 |
| 70 | MP0004510_myositis | 0.99041532 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.98986291 |
| 72 | MP0004043_abnormal_pH_regulation | 0.98665630 |
| 73 | MP0002132_abnormal_respiratory_system | 0.98324457 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.93875323 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.92896770 |
| 76 | MP0005174_abnormal_tail_pigmentation | 0.89694655 |
| 77 | MP0005390_skeleton_phenotype | 0.84747150 |
| 78 | MP0005164_abnormal_response_to | 0.83689417 |
| 79 | MP0003195_calcinosis | 0.81804101 |
| 80 | MP0000470_abnormal_stomach_morphology | 0.81623704 |
| 81 | MP0002928_abnormal_bile_duct | 0.81583326 |
| 82 | MP0008004_abnormal_stomach_pH | 0.81023280 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.81014494 |
| 84 | MP0008260_abnormal_autophagy | 0.79734707 |
| 85 | MP0000249_abnormal_blood_vessel | 0.79086911 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.78696575 |
| 87 | MP0000371_diluted_coat_color | 0.77960934 |
| 88 | MP0008995_early_reproductive_senescence | 0.75079423 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.72326885 |
| 90 | MP0005083_abnormal_biliary_tract | 0.68828468 |
| 91 | MP0003252_abnormal_bile_duct | 0.68369638 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.67393661 |
| 93 | MP0009115_abnormal_fat_cell | 0.65260019 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.64526745 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.63477329 |
| 96 | MP0003690_abnormal_glial_cell | 0.63435766 |
| 97 | MP0000427_abnormal_hair_cycle | 0.63345168 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.61525601 |
| 99 | MP0004742_abnormal_vestibular_system | 0.59482391 |
| 100 | MP0001958_emphysema | 0.58285036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.80000359 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.79509581 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.50784049 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.37609463 |
| 5 | Optic neuritis (HP:0100653) | 4.37609463 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.35012163 |
| 7 | Orchitis (HP:0100796) | 4.32405543 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.25496369 |
| 9 | Stomatitis (HP:0010280) | 4.21450196 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.12090903 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.04638234 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85117949 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85117949 |
| 14 | Pustule (HP:0200039) | 3.55134681 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.54332040 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.47141456 |
| 17 | Recurrent skin infections (HP:0001581) | 3.29652948 |
| 18 | Encephalitis (HP:0002383) | 3.22796143 |
| 19 | Increased IgE level (HP:0003212) | 3.12501457 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.10107865 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.05740863 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.04988388 |
| 23 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.02224631 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.01875450 |
| 25 | Keratoconjunctivitis (HP:0001096) | 2.99645439 |
| 26 | Meningitis (HP:0001287) | 2.98631861 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 2.95540478 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.94773851 |
| 29 | Hemoptysis (HP:0002105) | 2.93992944 |
| 30 | Vasculitis (HP:0002633) | 2.89631337 |
| 31 | T lymphocytopenia (HP:0005403) | 2.89148913 |
| 32 | Colitis (HP:0002583) | 2.86627939 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.84120006 |
| 34 | Hypochromic anemia (HP:0001931) | 2.83252128 |
| 35 | Genetic anticipation (HP:0003743) | 2.81157447 |
| 36 | Stomach cancer (HP:0012126) | 2.80104041 |
| 37 | Prolonged bleeding time (HP:0003010) | 2.79788863 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78822339 |
| 39 | Abnormality of T cells (HP:0002843) | 2.78634537 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.76949591 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.70700177 |
| 42 | Gingivitis (HP:0000230) | 2.60268250 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.60091951 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.59180495 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.58834045 |
| 46 | Recurrent viral infections (HP:0004429) | 2.50890921 |
| 47 | Leukocytosis (HP:0001974) | 2.50599734 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.49932884 |
| 49 | Obstructive lung disease (HP:0006536) | 2.47035403 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47035403 |
| 51 | Clumsiness (HP:0002312) | 2.41395687 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.37058748 |
| 53 | Chest pain (HP:0100749) | 2.35258613 |
| 54 | Cheilitis (HP:0100825) | 2.27224449 |
| 55 | Granulocytopenia (HP:0001913) | 2.22275895 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.20691803 |
| 57 | Episodic fever (HP:0001954) | 2.13996632 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.10569394 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10069037 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10069037 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10069037 |
| 62 | Epistaxis (HP:0000421) | 2.08393105 |
| 63 | Arterial thrombosis (HP:0004420) | 2.06351777 |
| 64 | Abnormality of the pleura (HP:0002103) | 2.04196814 |
| 65 | Eosinophilia (HP:0001880) | 2.01984870 |
| 66 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.01136060 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.00342269 |
| 68 | Abnormality of eosinophils (HP:0001879) | 1.99946413 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 1.99421477 |
| 70 | Anorexia (HP:0002039) | 1.98748470 |
| 71 | Progressive cerebellar ataxia (HP:0002073) | 1.97744356 |
| 72 | Pulmonary embolism (HP:0002204) | 1.95243892 |
| 73 | Keratitis (HP:0000491) | 1.94670838 |
| 74 | Urticaria (HP:0001025) | 1.94289072 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90513646 |
| 76 | Mucopolysacchariduria (HP:0008155) | 1.90513646 |
| 77 | Hyperventilation (HP:0002883) | 1.89741521 |
| 78 | Decreased circulating renin level (HP:0003351) | 1.88820229 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86177239 |
| 80 | Gangrene (HP:0100758) | 1.85983009 |
| 81 | Abnormality of the endocardium (HP:0004306) | 1.84189823 |
| 82 | Hematochezia (HP:0002573) | 1.82840933 |
| 83 | Gingival bleeding (HP:0000225) | 1.79907929 |
| 84 | Congenital stationary night blindness (HP:0007642) | 1.79317536 |
| 85 | Peritonitis (HP:0002586) | 1.78822871 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 1.78558371 |
| 87 | Cellulitis (HP:0100658) | 1.78124535 |
| 88 | Increased serum ferritin (HP:0003281) | 1.78102281 |
| 89 | Vertigo (HP:0002321) | 1.72715906 |
| 90 | Broad face (HP:0000283) | 1.71313799 |
| 91 | Obstructive sleep apnea (HP:0002870) | 1.68059600 |
| 92 | Amyloidosis (HP:0011034) | 1.67508307 |
| 93 | Widely spaced teeth (HP:0000687) | 1.66920921 |
| 94 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.65692181 |
| 95 | Hemiplegia (HP:0002301) | 1.64994682 |
| 96 | Alveolar cell carcinoma (HP:0006519) | 1.63680874 |
| 97 | Increased IgM level (HP:0003496) | 1.63514207 |
| 98 | Acne (HP:0001061) | 1.63396692 |
| 99 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.63165874 |
| 100 | Malnutrition (HP:0004395) | 1.62881903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.50715615 |
| 2 | RIPK4 | 3.16368550 |
| 3 | BLK | 2.74063992 |
| 4 | TAOK3 | 2.70635182 |
| 5 | TXK | 2.63463442 |
| 6 | TNK2 | 2.34801597 |
| 7 | FRK | 2.18886842 |
| 8 | TYK2 | 2.05119468 |
| 9 | IRAK4 | 2.01356454 |
| 10 | ZAP70 | 2.01142128 |
| 11 | MAP2K3 | 1.92472821 |
| 12 | GRK6 | 1.90622122 |
| 13 | FES | 1.90022226 |
| 14 | BTK | 1.68176604 |
| 15 | CSK | 1.66235062 |
| 16 | SIK2 | 1.63988080 |
| 17 | JAK3 | 1.63149940 |
| 18 | SYK | 1.61085965 |
| 19 | TRIB3 | 1.60185371 |
| 20 | IKBKE | 1.59432281 |
| 21 | ERN1 | 1.56572360 |
| 22 | ITK | 1.42102198 |
| 23 | KIT | 1.41715879 |
| 24 | HCK | 1.39044418 |
| 25 | MAP3K7 | 1.35882962 |
| 26 | MARK2 | 1.35724482 |
| 27 | EPHB1 | 1.35029892 |
| 28 | MAP3K14 | 1.32125058 |
| 29 | IKBKB | 1.26868617 |
| 30 | JAK1 | 1.25905837 |
| 31 | MAP3K13 | 1.24039755 |
| 32 | WNK4 | 1.22918987 |
| 33 | DAPK2 | 1.21265205 |
| 34 | LCK | 1.18634927 |
| 35 | ADRBK2 | 1.17172332 |
| 36 | TBK1 | 1.15208246 |
| 37 | MAP2K6 | 1.13137040 |
| 38 | MAP3K3 | 1.12313013 |
| 39 | CSF1R | 1.11319386 |
| 40 | CDC42BPA | 1.10572898 |
| 41 | PRPF4B | 1.10365618 |
| 42 | IRAK1 | 1.06563228 |
| 43 | LYN | 1.05295464 |
| 44 | TEC | 1.03368385 |
| 45 | MARK3 | 0.99257879 |
| 46 | WNK1 | 0.97925630 |
| 47 | SIK1 | 0.96867376 |
| 48 | PRKD2 | 0.95447610 |
| 49 | CHUK | 0.94326315 |
| 50 | ACVR1B | 0.90894685 |
| 51 | SIK3 | 0.90711246 |
| 52 | JAK2 | 0.90362642 |
| 53 | MAPK15 | 0.90116277 |
| 54 | PTK6 | 0.88141569 |
| 55 | PTK2B | 0.87985959 |
| 56 | PIK3CG | 0.87635762 |
| 57 | MAP3K6 | 0.87421251 |
| 58 | INSRR | 0.87385788 |
| 59 | TAOK1 | 0.87321911 |
| 60 | PDK1 | 0.83880000 |
| 61 | TRPM7 | 0.83509717 |
| 62 | MAP3K11 | 0.83227033 |
| 63 | CAMKK1 | 0.82230255 |
| 64 | HIPK2 | 0.79934356 |
| 65 | FGR | 0.79741579 |
| 66 | MAPK7 | 0.76996178 |
| 67 | CAMK1D | 0.76411352 |
| 68 | RPS6KA6 | 0.74253703 |
| 69 | PDPK1 | 0.71967252 |
| 70 | MAPK12 | 0.71921246 |
| 71 | TLK1 | 0.71498264 |
| 72 | PRKCQ | 0.71372001 |
| 73 | SGK2 | 0.66085249 |
| 74 | CAMKK2 | 0.65107133 |
| 75 | EPHA3 | 0.65013786 |
| 76 | MAP2K2 | 0.64162018 |
| 77 | CAMK4 | 0.64054578 |
| 78 | MAP4K2 | 0.63652989 |
| 79 | PRKAA2 | 0.63317941 |
| 80 | STK38 | 0.62886153 |
| 81 | MATK | 0.62444306 |
| 82 | NLK | 0.62182792 |
| 83 | ERBB2 | 0.61410936 |
| 84 | FGFR3 | 0.57483688 |
| 85 | MAPKAPK3 | 0.56135591 |
| 86 | RPS6KL1 | 0.55777921 |
| 87 | RPS6KC1 | 0.55777921 |
| 88 | ADRBK1 | 0.54643830 |
| 89 | STK11 | 0.53074103 |
| 90 | PDGFRB | 0.52446566 |
| 91 | MAP3K1 | 0.51634956 |
| 92 | PIK3CA | 0.51554578 |
| 93 | SGK3 | 0.50645347 |
| 94 | CDK12 | 0.48978677 |
| 95 | RPS6KA2 | 0.48904309 |
| 96 | IRAK2 | 0.47390926 |
| 97 | MAPK11 | 0.47190658 |
| 98 | TGFBR2 | 0.45895046 |
| 99 | BMPR1B | 0.45853434 |
| 100 | BMPR2 | 0.45679881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27535781 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12801528 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12522708 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10617333 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08408730 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 1.92088379 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86454575 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85709208 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84456381 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81252447 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.79756879 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78117659 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.75065188 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74308368 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68867805 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53567586 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.53401016 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51912702 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51393115 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49278706 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47777880 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45775932 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44502223 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39336645 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36079944 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36053297 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.34757982 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.28709931 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.27949449 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27831287 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24623505 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.19561377 |
| 33 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.17361249 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16897034 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.15474108 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.12685347 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10935948 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08828420 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08116940 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05026383 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00850316 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98454727 |
| 43 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97008604 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94365916 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94298292 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93731931 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92224973 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91402903 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91002852 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90013000 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89549213 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87515368 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85410183 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84437966 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81823143 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.81099058 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.80921512 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80677627 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.79963660 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.78043860 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77176123 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75808669 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.74701872 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.74206275 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74156709 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72878744 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72834796 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72724416 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72057882 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71814911 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71613446 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70566133 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70416453 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69943858 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68064406 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67828497 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65848748 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64339210 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63345518 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62967292 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62814784 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.61034174 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57728033 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.56523118 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55831269 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54518801 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54456083 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54300527 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53965989 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53591222 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.49280392 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48076216 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47867583 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47104685 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.46557698 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.45971964 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45485673 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45135836 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44695529 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44562255 |

